跳到正文
AI NEWS JOURNAL
AI, IN PERSPECTIVE

搜索 AI 资讯

检索标题、摘要与正文,把分散的信息连起来。

按发布时间排序

估值150亿美元的广告驱动型AI医疗初创公司OpenEvidence,或已被全美近三分之二医生使用

总部位于迈阿密的AI医疗搜索平台OpenEvidence成立于2022年,宣称已有近三分之二的美国医生使用其广告支持的AI聊天工具检索医学文献与临床指南,单月处理超4200万条医疗查询;该公司目前估值达150亿美元,但其准确性与广告模式引发对临床决策安全性的争议。

事件进展与其他报道

OpenAI acquires Orchestra Bio

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

译文排队中,当前为原文 · en
事件进展与其他报道

Anthropic tells investors quarterly revenue up nearly 50% to $16.8bn ahead of IPO

Anthropic tells investors quarterly revenue up nearly 50% to $16.8bn ahead of IPO The phrase "told investors" appears four times in this FT article, which reports on Anthropic's day of hosting investors on Wednesday. Lots of details in here from "people with knowledge of the matter". Key things I learned from the article: Q1 revenue (Jan/Feb/Mar) was "about $4.8bn" Q2 (Apr/May/Jun) was $11.5bn Q3 (Jul/Aug/Sep) was $16.8bn In Q3: $1.70 in revenue for every $1 spent on "computing power" Adjusted operating margins (excluding stock-based compensation) were 11% This point about distillation is worth quoting in full (highlight mine): The start-up has also clamped down on “distillation” — a controversial practice whereby rival AI labs train their models on the outputs of more advanced ones. When

译文排队中,当前为原文 · en
事件进展与其他报道